Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel total synthesis route for Oxonantenine offers high purity and scalable production for antitumor drug development supply chains.
Novel alkali metal halide catalyzed method ensures stable quality and high yield for hydrocortisone acetate manufacturing supply chain efficiency.
Patent CN104263796A details a high-yield chiral synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel patented route for high-purity nucleoside intermediates. Enhances solubility and yield for nucleic acid drug manufacturing supply chains.
Patent CN111377982B details a novel solid acid catalyzed glycosylation for decitabine intermediates, offering high beta-selectivity and simplified purification for pharmaceutical manufacturing.
Novel synthesis route for hypoglycemic drug molecule TAPA offering high yield and scalable production for pharmaceutical intermediate supply chains globally.
Novel organophosphine-catalyzed asymmetric [4+2] cycloaddition for high-purity chiral 3,4-dihydroquinazolin-2-ones. Scalable route with excellent enantioselectivity up to 92% ee.
Novel patent CN105873938A details a high-yield regadenoson process avoiding genotoxic impurities ensuring supply chain stability and cost reduction in API manufacturing.
Patent CN103044315A reveals solvent-free 1,4-dihydropyridine synthesis. Acidic ionic liquid catalyst ensures high yield and supply chain reliability for pharmaceutical intermediates.
Patent CN104529803B reveals a novel amide synthesis route using triethylenediamine. Achieve cost reduction in pharmaceutical intermediates manufacturing with high purity.
Novel slurry purification method controls 2-ethylpentanoic acid impurity ensuring European Pharmacopoeia compliance and supply chain stability for pharmaceutical intermediates.
Patent CN102712593B reveals improved synthesis using hydrophilic ethers. Achieves high purity and reduced reaction time for scalable pharmaceutical intermediates manufacturing.
Novel resolution process for chiral piperidine intermediates. Reduces steps and cost for pharmaceutical manufacturing. Reliable supply chain partner.
Patent CN1452621A details a novel cyclohexanone-based route for substituted imidazopyridines, offering superior yields and scalability for gastric acid inhibitor intermediates.
Patent CN106589037A reveals a novel two-step progesterone synthesis. Achieve high purity and cost reduction in hormone manufacturing with scalable industrial processes.
Patent CN110845388A reveals a novel 3-step synthesis of 7-nitroindole from o-nitroaniline. Discover cost-effective, scalable production methods for high-purity intermediates.
Novel synthesis route offers high yield and safety for finafloxacin intermediate production. Reduces toxic waste and ensures supply chain stability for global pharmaceutical manufacturers seeking reliable partners.
Discover the novel asymmetric synthesis of Triptolide via chiral phase transfer catalysis. Enhance supply chain reliability and reduce costs in API manufacturing with our scalable route.
Patent CN121108236A reveals a safe pivalic anhydride method for N-methylated polypeptide synthesis, offering high purity and cost reduction for pharmaceutical manufacturing.
Novel nickel-catalyzed cyanation route for high-purity pharma intermediates. Delivers significant cost reduction in pharma manufacturing and reliable supply chain continuity.